Cargando…
A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies
The value of combination therapy for refractory ITP is not well defined. We present the case of a 29-year-old male with severe ITP refractory to initial standard therapy including steroids, IVIG, and subsequent splenectomy, who was treated with the combination therapy of rituximab, romiplostim, and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051095/ https://www.ncbi.nlm.nih.gov/pubmed/30057832 http://dx.doi.org/10.1155/2018/8207017 |